The private equity firm intends to take advantage of Europe’s fragmented dental laboratory sector and an increase in privately funded dental treatments.
London-based Queen’s Park Equity has backed the management buyout of London digital dental laboratory MediMatch.
Financial details have not been disclosed.
The firm serves more than 2,000 dentists nationally and has a presence in Europe with labs in Dublin, Milan and Paris.
Queen’s Park Equity was attracted by what the firm’s lead Sami Igout calls the firm’s “impressive organic growth”. MediMatch has been growing at around 20% a year over the past three years.
“Their success is testament to both the quality and speed at which they serve their customers due to their digital-led approach,” he continued.
Queen’s Park Equity says that it intends to help the firm both capitalise on a consolidation strategy in the fragmented UK and EU dental laboratory sector and benefit from an increase in privately funded dental treatments and the acceleration of the use of intra-oral scanners by dentists globally.
MediMatch is the eleventh partnership investment from Queen’s Park Equity Fund I, which was oversubscribed and closed at its hard cap of £202 million in December 2020. Its other healthcare investments include Blue Ribbon, a provider of adult residential care and supported living services; Psych-UK, a provider of digital psychiatry services; and Republic M, a provider of outsourced commercialisation services to the pharmaceutical industry.
